THRD Live signals | Maximize Profits with Getagraph.com

BUY 136124 min ago

@ $9.00

Issued: 13 Feb 2024 @ 12:30

Return: 54.06%

Previous signal: Feb 6 - 13:49

Previous signal: Sell

Return: -2.39 %

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases...

Stats
Today's Volume	61 300.00
Average Volume	151 816
Market Cap	567.76M
EPS	$0.195 ( 2024-05-16 )
Next earnings date	( $-0.330 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-17.78
ATR14	$0.0400 (0.29%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-09	Holles Natalie C.	Buy	20 222	Common Stock
2024-05-09	Holles Natalie C.	Sell	20 222	Common Stock
2024-05-09	Holles Natalie C.	Sell	20 222	Employee Stock Option (right to buy)
2024-04-11	Holles Natalie C.	Buy	13 558	Common Stock
2024-04-11	Holles Natalie C.	Sell	13 558	Common Stock

INSIDER POWER
-5.71
Last 98 transactions
Buy: 17 555 771 \| Sell: 27 318 325

Volume Correlation

Long: 0.18 (neutral)

Short: 0.53 (weak)

Signal:(51.903) Neutral

Third Harmonic Bio, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Third Harmonic Bio, Inc. Correlation - Currency/Commodity

-0.91
( very strong negative )

-0.87
( strong negative )

0.00
( neutral )

-0.22
( neutral )

-0.69
( moderate negative )

0.50
( neutral )

Third Harmonic Bio, Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-35 000.00 (0.00 %)
EPS:	$-0.780

FY	2023
Revenue:	$0
Gross Profit:	$-35 000.00 (0.00 %)
EPS:	$-0.780

FY	2022
Revenue:	$0
Gross Profit:	$-38 000.00 (0.00 %)
EPS:	$-0.960

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-1.730

Financial Reports:

No articles found.

Third Harmonic Bio, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Third Harmonic Bio, Inc.

Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.